Soft Tissue Width and Abutment Height Influence Peri-implant Bone Resorption
NCT ID: NCT03229005
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2017-05-15
2019-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Thickness of the Peri-implant Soft Tissue on Marginal Bone Remodeling
NCT03077880
Implant Abutment Dis-/Reconnection and Peri-Implant Marginal Bone Loss.
NCT02617212
Apico-coronal Position of Tissue-level Implants Bone Stability
NCT05363306
Soft Tissue Thickness on Submerged and Non Submerged Implants
NCT02842385
Bone Dimensional Changes at Different Implant-to-abutment Connections: a 1-year Clinical and Radiological Study
NCT01807416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients will receive antibiotic prophylaxis with 2 g of amoxicillin one hour before surgery. With the help of a dissector, a full thickness vestibular flap will be carefully arranged and the vertical thickness of soft tissues will be measured with a probe marked every 1.0 mm. If the vertical thickness of the soft tissue is 2 mm or less, the tissue will be considered thin. If the thickness of the mucosa is greater than 2 mm, it will be considered thick. After the measurement, the lingual flap will be elevated at full thickness, and the site for site placement will be prepared. The implant bed will be at least 1.5 mm from the adjacent tooth or teeth, and must be surrounded by at least 1 mm bone in both buccal and lingual directions. A 3,75 mm diameter and internal hexagonal connection implant will be placed at the level of the bone crest according to the manufacturer's recommendations. Operators will be free to choose the most suitable system length (8, 10, 11.5 mm). All implants will be submerged according to a traditional two-stage protocol. After insertion, the flaps will be sutured without tension with interrupted sutures. Patients of both groups will be instructed to disinfect the site by rinsing twice daily for one week for 1 minute with 0.12% chlorhexidine. After 4 months of healing, the treated area will be reopened for connecting the healing abutments with a crestal incision that will retain the keratinized tissue; The same soft tissue measurements will be repeated as confirmation of what was done during the first surgical implant insertion phase. The implants will be considered osteointegrated successfully if they are clinically intact unless they show obvious radiotransparency and patients will not report any pain. After this step, it will be possible to divide the patients into 2 groups according to the thickness of the soft tissue: a group with thick tissue (more than 2.0 mm); Slim tissue group (less than 2.0 mm). The prosthetic framework will be bonded directly to prefabricated titanium abutment (1 or 3 mm). This will result in the formation of 4 different subgroups: a group with thick tissue and high prosthetic abutment; A group with thick tissue and low prosthetic stump; a group with thin tissue and high prosthetic abutment; a group with thin tissue and low prosthetic abutment.
All the implants will be rehabilitated by the dentist with screwed restorations. After prosthetic treatment, patients will receive oral hygiene instructions and will be monitored through calls to ensure periodontal health throughout the study period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A1 thick-high
group with thick tissue and high prosthetic abutment tissue measurement implant insertion operculectomy prosthetic rehabilitation
implant insertion
during surgery soft tissues will be measured
operculectomy
during second surgery soft tissues will be measured again
prosthetic rehabilitation
after three months implants will be loaded with screw retained crown
A2 thick-low
group with thick tissue and low prosthetic abutment tissue measurement implant insertion operculectomy prosthetic rehabilitation
implant insertion
during surgery soft tissues will be measured
operculectomy
during second surgery soft tissues will be measured again
prosthetic rehabilitation
after three months implants will be loaded with screw retained crown
B1 thin-high
group with thin tissue and high prosthetic abutment tissue measurement implant insertion operculectomy prosthetic rehabilitation
implant insertion
during surgery soft tissues will be measured
operculectomy
during second surgery soft tissues will be measured again
prosthetic rehabilitation
after three months implants will be loaded with screw retained crown
B2 thin-low
group with thin tissue and low prosthetic abutment tissue measurement implant insertion operculectomy prosthetic rehabilitation
implant insertion
during surgery soft tissues will be measured
operculectomy
during second surgery soft tissues will be measured again
prosthetic rehabilitation
after three months implants will be loaded with screw retained crown
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
implant insertion
during surgery soft tissues will be measured
operculectomy
during second surgery soft tissues will be measured again
prosthetic rehabilitation
after three months implants will be loaded with screw retained crown
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* good general health;
* non smokers;
* absence of systemic diseases affecting bone metabolism and wound healing; - no regular medication consumption for at least 3 months prior to treatment; - patient willing and fully capable to comply with the study protocol;
* written informed consent given.
* presence of keratinized mucosa with a minimum bucco-lingual width of 3 mm; - bone crest with at least 6 mm of width and 9 mm of height above the mandibular canal, without concomitant or previous bone augmentation procedures;
* presence of the opposing dentition.
Exclusion Criteria
* uncontrolled diabetes (HBA1c \>7.5%);
* active infections;
* immunocompromised patients (HIV infection or chemotherapy within the past 5 years);
* present or past treatment with intravenous bisphosphonates;
* patient pregnancy or lactating at any time during the study;
* poor oral hygiene and motivation;
* untreated periodontal disease;
* psychological or psychiatric problems;
* alcohol or drugs abuse;
* participating in other studies, if the present protocol could not be properly followed;
* lack of implant primary stability.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Piezosurgery Academy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mr. Claudio Stacchi, DDS, MSc
President of the Academy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudio Stacchi, Dr.
Role: PRINCIPAL_INVESTIGATOR
Piezosurgery Academy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Piezosurgery Academy
Parma, PR, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Galindo-Moreno P, Leon-Cano A, Monje A, Ortega-Oller I, O'Valle F, Catena A. Abutment height influences the effect of platform switching on peri-implant marginal bone loss. Clin Oral Implants Res. 2016 Feb;27(2):167-73. doi: 10.1111/clr.12554. Epub 2015 Feb 11.
Linkevicius T, Apse P, Grybauskas S, Puisys A. Influence of thin mucosal tissues on crestal bone stability around implants with platform switching: a 1-year pilot study. J Oral Maxillofac Surg. 2010 Sep;68(9):2272-7. doi: 10.1016/j.joms.2009.08.018.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
i-RES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.